SCM
CERE

Segantii Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$48.3M Buy
1,143,426
+548,907
+92% +$23.2M 3.15% 8
2023
Q4
$25.2M Buy
+594,519
New +$25.2M 1.32% 19